Received Mar 11, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Z005469 | — |
No additional AE; GARDASIL 9 did have a temperature excursion prior to the administration; Patient received an expired GARDASIL 9 vaccine on 3/10/2026; This spontaneous report was received from a pharmacist and referred to a patient of unknown age and gender. The patient's medical history, past medications, and concomitant medications were not reported. On 10-Mar-2026, the patient was vaccinated with an expired Human Papillomavirus Nonavalent (Types 6, 11, 16, 18, 31, 33, 45, 52, 58) (Gardasil 9) suspension for injection, 1 dose (Batch/lot number Z005469 has been verified to be a valid batch lot number for Human Papillomavirus Nonavalent [Types 6, 11, 16, 18, 31, 33, 45, 52, 58], expiration date reported and confirmed as 27-Feb-2026) administered as prophylaxis (route of administration and anatomical location were not provided) (Expired product administered). The reporter stated that the vaccine administered had experienced a temperature excursion prior to administration (Product storage error); however, the details were not available at the time of the report. The type of temperature excursion (high and/or low), its duration, and whether there had been any previous excursions were all unknown. The reporter indicated that she would call back to provide the temperature and timeframe information. No additional adverse events (AEs) were reported.